Yelp Inc up 22% since May 15th
Yelp is putting the "!" back where it counts. Yelp! or Yelp Inc. (YELP) shares are up 22% since in less than 2 weeks. Just when web 2.0 heavily shorted stocks were the death of investors portfolios, Yelp is making a come back.
The chart clearly shows that Yelp is on the up and up. It appears to be a short squeeze that is working for traders now going long.
This San Francisco-based company saw its short interest surge more than 31 percent in the first weeks of May to more than 9.27 million shares, which represents more than 15 percent of the float. The number of shares sold short has been rising since mid-March. The days to cover remained about one
The 22% increase is a wake-up call to the short sellers. The stock continues to rally today up 5%.
Bottom line: Yelp appears to be on the mend but it still remains a volatile trade. If enough short interest exits the stock will continue to climb.
Best of the Blogs
Scanning and identifying the best blog entries every hour
- The "Minimum Wage" Surged In 6 Cities Last Year; Then This Happened | ZeroHedge
- The Mad Stewards of Gondor | Financial Sense
- The Federal Reserve - The Deep State's Central Bank | ZeroHedge
- Market Recap Feb 5, 2016 | FundMyMutualFund
- Lakshman on US Slowdown, Shocks, and China | Financial Sense
- All Job Gains Since December 2007 Have Gone To Foreign-Born Workers | ZeroHedge
- Your Last Minute Payrolls Preview: What Wall Street Expects | ZeroHedge
The most relevant financial news and articles from the Internets
- This is what regret looks like for the Pentagon | Business Insider
- The FBI's most violent cities in each state | Business Insider
- Donald Trump and Marco Rubio could be top targets... | Business Insider
- Hillary Clinton delivered a powerful answer about how her ego influences her... | Business Insider
- Syrian President Bashar al-Assad's mother has... | Business Insider
- This is what it looks like when 100,000 people in China try to get home... | Business Insider
- An LA doctor faces life in prison for overprescribing... | Business Insider